SCHEMBL4802136

SCHEMBL4802136

COc1cccc(C(=O)N[C@@H](CC(C)(C)C)C(=O)N[C@@H](COCc2ccccc2)CN2CCc3cc(F)ccc32)c1

nearest known ligand 0.79

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CTSS P25774 20/20 0.79
CTSL P07711 15/20 0.79
CTSK P43235 9/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4802130 1.00 CTSS (0.79) CTSSCTSLCTSK
SCHEMBL4795267 0.91 CTSS (0.78) CTSSCTSLCTSK
SCHEMBL4795264 0.91 CTSS (0.78) CTSSCTSLCTSK
SCHEMBL4798631 0.88 CTSS (1.00) CTSSCTSLCTSK
SCHEMBL4798662 0.88 CTSS (1.00) CTSSCTSLCTSK
SCHEMBL4798620 0.88 CTSS (1.00) CTSSCTSLCTSK
SCHEMBL4802182 0.88 CTSS (0.85) CTSSCTSLCTSK
SCHEMBL4802175 0.88 CTSS (0.85) CTSSCTSLCTSK
SCHEMBL4799707 0.88 CTSS (0.73) CTSSCTSLCTSK
SCHEMBL4799713 0.88 CTSS (0.73) CTSSCTSLCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080242671-A1 INHIBITORS OF CATHEPSIN S IRM LLC (BM) 2008-10-02 US claimed
US-20080242671-A1 INHIBITORS OF CATHEPSIN S IRM LLC (BM) 2008-10-02 US disclosed
US-7384970-B2 Inhibitors of cathepsin S IRM LLC (BM) 2008-06-10 US disclosed
US-20040248887-A1 Inhibitors of cathepsin S IRM LLC (BM) 2004-12-09 US disclosed
WO-2004084843-A2 INHIBITORS OF CATHEPSIN S IRM LLC (BM) 2004-10-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040248887-A1 Inhibitors of cathepsin S CTSS, CTSB, CTSZ CTSS 1/4885CTSL 11/4885CTSK 9/4885
US-20080242671-A1 INHIBITORS OF CATHEPSIN S CTSS, CTSB, CTSZ CTSS 1/4885CTSL 11/4885CTSK 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.